Overview
Mark Tully practices practicing medicine in Grenoble, France.
His clinical expertise encompasses Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Genital Dwarfism.
He is actively involved in clinical research, co-authoring 35 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mark D. Tully
Is Mark D. Tully a top-rated expert for Primary Lateral Sclerosis?
MediFind is an objective health platform that identifies experts based on real-world data. Mark D. Tully is classified as an Experienced expert for Primary Lateral Sclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mark D. Tully participate in research or clinical trials?
Yes. Mark D. Tully has published 35 articles and abstracts on conditions like Primary Lateral Sclerosis. You can view a list of Mark D. Tully's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Genital DwarfismMr. Tully isExperienced. Learn about Genital Dwarfism.
- Primary Lateral SclerosisMr. Tully isExperienced. Learn about Primary Lateral Sclerosis.